168 related articles for article (PubMed ID: 36882524)
41. Negative Regulation of the Keap1-Nrf2 Pathway by a p62/Sqstm1 Splicing Variant.
Kageyama S; Saito T; Obata M; Koide RH; Ichimura Y; Komatsu M
Mol Cell Biol; 2018 Apr; 38(7):. PubMed ID: 29339380
[TBL] [Abstract][Full Text] [Related]
42. TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability.
Zhou S; Peng J; Xiao L; Zhou C; Fang Y; Ou Q; Qin J; Liu M; Pan Z; Hou Z
Cell Death Dis; 2021 May; 12(5):463. PubMed ID: 33966039
[TBL] [Abstract][Full Text] [Related]
43. Associations between the Nrf2/Keap1 pathway and mitochondrial functions in colorectal cancer are affected by metastasis.
Chang LC; Fan CW; Tseng WK; Hua CC
Cancer Biomark; 2020; 27(2):163-171. PubMed ID: 31796664
[TBL] [Abstract][Full Text] [Related]
44. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
[TBL] [Abstract][Full Text] [Related]
45. CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells.
Wang Q; Ma J; Lu Y; Zhang S; Huang J; Chen J; Bei JX; Yang K; Wu G; Huang K; Chen J; Xu S
Oncogene; 2017 Sep; 36(37):5321-5330. PubMed ID: 28534518
[TBL] [Abstract][Full Text] [Related]
46. The level of S-glutathionylated protein is a predictor for metastasis in colorectal cancer and correlated with those of Nrf2/Keap1 pathway.
Chang LC; Fan CW; Tseng WK; Hua CC
Biomarkers; 2021 Dec; 26(8):780-787. PubMed ID: 34704878
[TBL] [Abstract][Full Text] [Related]
47. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
[TBL] [Abstract][Full Text] [Related]
48. Methylation of the KEAP1 gene promoter region in human colorectal cancer.
Hanada N; Takahata T; Zhou Q; Ye X; Sun R; Itoh J; Ishiguro A; Kijima H; Mimura J; Itoh K; Fukuda S; Saijo Y
BMC Cancer; 2012 Feb; 12():66. PubMed ID: 22325485
[TBL] [Abstract][Full Text] [Related]
49. SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner.
Rada P; Rojo AI; Chowdhry S; McMahon M; Hayes JD; Cuadrado A
Mol Cell Biol; 2011 Mar; 31(6):1121-33. PubMed ID: 21245377
[TBL] [Abstract][Full Text] [Related]
50. TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer.
Zhang B; Wu J; Cai Y; Luo M; Wang B; Gu Y
Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):375-385. PubMed ID: 30811526
[TBL] [Abstract][Full Text] [Related]
51. CASC21, a FOXP1 induced long non-coding RNA, promotes colorectal cancer growth by regulating CDK6.
Gong T; Li Y; Feng L; Fang M; Dai G; Huang X; Yang Y; Liu S
Aging (Albany NY); 2020 Jun; 12(12):12086-12106. PubMed ID: 32584787
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth.
Yan H; Ren S; Lin Q; Yu Y; Chen C; Hua X; Jin H; Lu Y; Zhang H; Xie Q; Huang C; Huang H
FASEB J; 2019 Nov; 33(11):12112-12123. PubMed ID: 31373842
[TBL] [Abstract][Full Text] [Related]
53. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
[TBL] [Abstract][Full Text] [Related]
54. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.
Zhang DD; Lo SC; Cross JV; Templeton DJ; Hannink M
Mol Cell Biol; 2004 Dec; 24(24):10941-53. PubMed ID: 15572695
[TBL] [Abstract][Full Text] [Related]
55. Down-regulated C4orf19 confers poor prognosis in colon adenocarcinoma identified by gene co-expression network.
Wang W; Lin X; Yu R; Zhou S; Liu Y; Jia H; Han F; Bu Y; Pu J
J Cancer; 2022; 13(4):1145-1159. PubMed ID: 35281862
[TBL] [Abstract][Full Text] [Related]
56. p62 promotes bladder cancer cell growth by activating KEAP1/NRF2-dependent antioxidative response.
Li T; Jiang D; Wu K
Cancer Sci; 2020 Apr; 111(4):1156-1164. PubMed ID: 31967368
[TBL] [Abstract][Full Text] [Related]
57. Upregulation of nuclear factor (erythroid-derived 2)-like 2 protein level in the human colorectal adenocarcinoma cell line DLD-1 by a heterocyclic organobismuth(III) compound: Effect of organobismuth(III) compound on NRF2 signaling.
Iuchi K; Tasaki Y; Shirai S; Hisatomi H
Biomed Pharmacother; 2020 May; 125():109928. PubMed ID: 32004978
[TBL] [Abstract][Full Text] [Related]
58. DUB3 deubiquitinates and stabilizes NRF2 in chemotherapy resistance of colorectal cancer.
Zhang Q; Zhang ZY; Du H; Li SZ; Tu R; Jia YF; Zheng Z; Song XM; Du RL; Zhang XD
Cell Death Differ; 2019 Nov; 26(11):2300-2313. PubMed ID: 30778200
[TBL] [Abstract][Full Text] [Related]
59. miR-141-3p inhibits vascular smooth muscle cell proliferation and migration via regulating Keap1/Nrf2/HO-1 pathway.
Zhang C; Kong X; Ma D
IUBMB Life; 2020 Oct; 72(10):2167-2179. PubMed ID: 32897647
[TBL] [Abstract][Full Text] [Related]
60. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
